SI-BONE Inc
NASDAQ:SIBN
SI-BONE Inc
Revenue
SI-BONE Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
SI-BONE Inc
NASDAQ:SIBN
|
Revenue
$167.2m
|
CAGR 3-Years
23%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$20.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$16.7B
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$22.6B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$42B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$8.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
15%
|
|
SI-BONE Inc
Revenue Breakdown
Breakdown by Geography
SI-BONE Inc
|
Total Revenue:
167.2m
USD
|
|
United States:
158.4m
USD
|
|
International:
8.8m
USD
|
Breakdown by Segments
SI-BONE Inc
SI-BONE Inc
Glance View
SI-BONE, Inc. engages in the provision of implantable devices used in the surgical treatment of the sacropelvic anatomy. The company is headquartered in Santa Clara, California and currently employs 352 full-time employees. The company went IPO on 2018-10-17. The firm is focused on the development of implantable devices used in the surgical treatment of sacro-pelvic anatomy. Its invasive surgical implant system, iFuse, is used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. Its iFuse Implant System includes a series of triangular titanium implants and the instruments developed to enable surgeons to perform the procedure. Its iFuse system, which includes its implants and instruments, is designed to address the shortcomings of alternative treatments, including open surgery, non-surgical management, and screw-based and other minimally invasive stabilization and fusion procedures. Its iFuse-3D design allows the surgeons to fill the implant with ground-up bone before implantation, which accelerates bone through-growth and biological fixation. The company also provides other technologies for its surgeons other than iFuse and iFuse-3D.
See Also
What is SI-BONE Inc's Revenue?
Revenue
167.2m
USD
Based on the financial report for Dec 31, 2024, SI-BONE Inc's Revenue amounts to 167.2m USD.
What is SI-BONE Inc's Revenue growth rate?
Revenue CAGR 5Y
20%
Over the last year, the Revenue growth was 20%. The average annual Revenue growth rates for SI-BONE Inc have been 23% over the past three years , 20% over the past five years .
You don't have any saved screeners yet